The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis.
Oxford, Sanger Institute Researchers Draw on Gene Expression Testing for Sepsis Risk Algorithm
The algorithm distinguishes between groups of patients who are at high risk of developing severe illness and those who are low risk.
SkylineDx Gains CE-IVD Mark for Melanoma Metastasis Risk Assay
The Netherlands-based firm is partnering with Belgian company Biocartis on European commercialization of the qPCR assay, which could reduce unnecessary surgeries.
GenDx Licenses cfDNA Assay for Rejection Monitoring From Medical College of Wisconsin
The method allows for less invasive and more economical post-transplant monitoring and could also be adapted for other organ applications.
The new tests, once developed, will be used for selecting patients who might best benefit from therapies for kidney disease, nonalcoholic steatohepatitis, and respiratory disease.